Cowen and Company’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,663,614
| Closed | -$75.1K | – | 666 |
|
|
2024
Q2 | $75.1K | Buy |
2,663,614
+1,281,281
| +93% | +$36.1K | ﹤0.01% | 265 |
|
|
2024
Q1 | $124K | Buy |
1,382,333
+454,764
| +49% | +$40.9K | ﹤0.01% | 253 |
|
|
2023
Q4 | $97.7K | Buy |
927,569
+484,367
| +109% | +$51K | 0.01% | 244 |
|
|
2023
Q3 | $99.7K | Buy |
443,202
+185,485
| +72% | +$41.7K | 0.01% | 243 |
|
|
2023
Q2 | $67.6K | Buy |
257,717
+67,099
| +35% | +$17.6K | 0.01% | 258 |
|
|
2023
Q1 | $34.3K | Sell |
190,618
-60,408
| -24% | -$10.9K | ﹤0.01% | 243 |
|
|
2022
Q4 | $50.2K | Buy |
+251,026
| New | +$50.2K | 0.01% | 236 |
|